Wegovy: 113/288 returned four-engine answers (39.2%; 95% interval 33.8–45.0%). Three or more leading intervals overlap; no sole leader is established.
RESEARCH · Published June 22, 2026 · Updated November 9, 2026
Weight Loss Index 2.0: Wegovy Tops a Close Field
AI answers analyzed across ChatGPT, Claude, Gemini and Perplexity
of answers named Wegovy, the most-named (113 of 288)
tracked brands named at least once (of 39)
of Google searches showed an AI Overview (55 of 60)
Version 2. This version replaces the first version of this study, first published April 27, 2026. It uses measured counts, so the two versions are not comparable. Version 2 asks 24 questions three times each on ChatGPT, Claude, Gemini and Perplexity (288 answers) and adds Google AI Overviews. Every rate comes with its count and a 95% interval.
What the data shows
Wegovy
51/288 (17.7%)
39/288 (13.5%)
55/60 (91.7%)
20/55 (36.4%)
75/288 (26%)
Appearance rate across 288 four-engine answers. The bar is the 95% confidence interval; overlapping bars cannot be told apart at this sample size.
Which brands AI engines name
| # | Name | Named in | Appearance rate | 95% interval |
|---|---|---|---|---|
| 1 | Wegovy | 113/288 | 39.2% | 33.8–45.0% |
| 2 | Zepbound | 97/288 | 33.7% | 28.5–39.3% |
| 3 | Noom | 96/288 | 33.3% | 28.1–39.0% |
| 4 | WeightWatchers | 92/288 | 31.9% | 26.8–37.5% |
| 5 | MyFitnessPal | 69/288 | 24.0% | 19.4–29.2% |
| 6 | Ozempic | 65/288 | 22.6% | 18.1–27.7% |
| 7 | Cronometer | 59/288 | 20.5% | 16.2–25.5% |
| 8 | Lose It! | 52/288 | 18.1% | 14.0–22.9% |
| 9 | Saxenda | 44/288 | 15.3% | 11.6–19.9% |
| 10 | Mounjaro | 43/288 | 14.9% | 11.3–19.5% |
| 11 | Ro | 40/288 | 13.9% | 10.4–18.4% |
| 12 | Hims & Hers | 36/288 | 12.5% | 9.2–16.8% |
| 13 | Nutrisystem | 29/288 | 10.1% | 7.1–14.1% |
| 14 | Factor | 27/288 | 9.4% | 6.5–13.3% |
| 15 | MacroFactor | 25/288 | 8.7% | 5.9–12.5% |
The full list
Own-domain citation is the share of 288 grounded answers that cited the tracked name's own domains (subdomains included). Citation share is of all 2,465 citations. Question 2 names Wegovy and Zepbound; Question 3 names Ozempic and Wegovy; Question 5 names Noom; Question 6 names WeightWatchers and Noom, so those counts include up to 12 answers each that name them by design. Removing 4 Core questions naming tracked subjects leaves 240 eligible answers. The top two are Wegovy (88/240) and Zepbound (84/240); their order does not change.
| # | Brand | Named in | Appearance rate | 95% interval | First mention | Own-domain citation | Citation share |
|---|---|---|---|---|---|---|---|
| 1 | Wegovy | 113/288 | 39.2% | 33.8–45% | 2 | 0.7% (2/288) | 0.1% |
| 2 | Zepbound | 97/288 | 33.7% | 28.5–39.3% | 3 | 1% (3/288) | 0.1% |
| 3 | Noom | 96/288 | 33.3% | 28.1–39% | 3 | 8.7% (25/288) | 1.5% |
| 4 | WeightWatchers | 92/288 | 31.9% | 26.8–37.5% | 2.3 | 13.5% (39/288) | 1.7% |
| 5 | MyFitnessPal | 69/288 | 24% | 19.4–29.2% | 2.2 | 4.5% (13/288) | 0.5% |
| 6 | Ozempic | 65/288 | 22.6% | 18.1–27.7% | 3 | 0% (0/288) | 0% |
| 7 | Cronometer | 59/288 | 20.5% | 16.2–25.5% | 2 | 3.8% (11/288) | 0.5% |
| 8 | Lose It! | 52/288 | 18.1% | 14–22.9% | 3 | 0.7% (2/288) | 0.1% |
| 9 | Saxenda | 44/288 | 15.3% | 11.6–19.9% | 3.7 | 0% (0/288) | 0% |
| 10 | Mounjaro | 43/288 | 14.9% | 11.3–19.5% | 4.3 | 0% (0/288) | 0% |
| 11 | Ro | 40/288 | 13.9% | 10.4–18.4% | 3.4 | 5.6% (16/288) | 0.6% |
| 12 | Hims & Hers | 36/288 | 12.5% | 9.2–16.8% | 4.9 | 3.5% (10/288) | 0.4% |
| 13 | Nutrisystem | 29/288 | 10.1% | 7.1–14.1% | 3.5 | 2.4% (7/288) | 0.3% |
| 14 | Factor | 27/288 | 9.4% | 6.5–13.3% | 1.4 | 2.8% (8/288) | 0.3% |
| 15 | MacroFactor | 25/288 | 8.7% | 5.9–12.5% | 3.2 | 0% (0/288) | 0% |
| 16 | Calibrate | 24/288 | 8.3% | 5.7–12.1% | 4.8 | 2.1% (6/288) | 0.2% |
| 17 | Alli | 23/288 | 8% | 5.4–11.7% | 3 | 1% (3/288) | 0.1% |
| 18 | Trifecta Nutrition | 23/288 | 8% | 5.4–11.7% | 2 | 2.1% (6/288) | 0.3% |
| 19 | Mochi Health | 22/288 | 7.6% | 5.1–11.3% | 7.7 | 0% (0/288) | 0% |
| 20 | Jenny Craig | 20/288 | 6.9% | 4.5–10.5% | 3.7 | 0.7% (2/288) | 0.1% |
| 21 | LifeMD | 14/288 | 4.9% | 2.9–8% | 7.6 | 1% (3/288) | 0.1% |
| 22 | Carb Manager | 13/288 | 4.5% | 2.7–7.6% | 1.2 | 1% (3/288) | 0.1% |
| 23 | Optavia | 12/288 | 4.2% | 2.4–7.1% | 3.5 | 0.3% (1/288) | 0% |
| 24 | Yazio | 12/288 | 4.2% | 2.4–7.1% | 3.5 | 0.3% (1/288) | 0% |
| 25 | Form Health | 10/288 | 3.5% | 1.9–6.3% | 7.8 | 0% (0/288) | 0% |
| 26 | Found | 10/288 | 3.5% | 1.9–6.3% | 7.3 | 2.4% (7/288) | 0.3% |
| 27 | Fastic | 9/288 | 3.1% | 1.7–5.8% | 2.3 | 0% (0/288) | 0% |
| 28 | Green Chef | 9/288 | 3.1% | 1.7–5.8% | 2.8 | 0% (0/288) | 0% |
The full list (continued)
None means no own site is tracked for that name.
| # | Brand | Named in | Appearance rate | 95% interval | First mention | Own-domain citation | Citation share |
|---|---|---|---|---|---|---|---|
| 29 | Henry Meds | 8/288 | 2.8% | 1.4–5.4% | 7.1 | 0% (0/288) | 0% |
| 30 | Hydroxycut | 8/288 | 2.8% | 1.4–5.4% | 1 | 0.3% (1/288) | 0% |
| 31 | Simple | 8/288 | 2.8% | 1.4–5.4% | 1.8 | 0.3% (1/288) | 0% |
| 32 | Zero | 6/288 | 2.1% | 1–4.5% | 1 | 0% (0/288) | 0% |
| 33 | Plenity | 4/288 | 1.4% | 0.5–3.5% | 4.5 | None | None |
| 34 | Eden | 3/288 | 1% | 0.4–3% | 11 | None | None |
| 35 | Territory Foods | 2/288 | 0.7% | 0.2–2.5% | 3 | None | None |
| 36 | Leanbean | 0/288 | 0% | 0–1.3% | – | None | None |
| 37 | Lumen | 0/288 | 0% | 0–1.3% | – | 0% (0/288) | 0% |
| 38 | PhenQ | 0/288 | 0% | 0–1.3% | – | 0% (0/288) | 0% |
| 39 | Profile by Sanford | 0/288 | 0% | 0–1.3% | – | None | None |
Question group: GLP-1 and prescription medications
72 returned four-engine answers to this group's 6 questions. No pooled group leader is asserted.
| # | Name | Named answers | Rate | 95% interval | Named first |
|---|---|---|---|---|---|
| 1 | Wegovy | 72/72 | 100.0% | 94.9–100.0% | 15 |
| 2 | Zepbound | 58/72 | 80.6% | 70.0–88.0% | 27 |
| 3 | Ozempic | 42/72 | 58.3% | 46.8–69.0% | 30 |
| 4 | Saxenda | 32/72 | 44.4% | 33.5–55.9% | 0 |
| 5 | Mounjaro | 30/72 | 41.7% | 31.0–53.2% | 0 |
| 6 | Plenity | 3/72 | 4.2% | 1.4–11.5% | 0 |
Question group: Telehealth weight loss providers
36 returned four-engine answers to this group's 3 questions. No pooled group leader is asserted.
| # | Name | Named answers | Rate | 95% interval | Named first |
|---|---|---|---|---|---|
| 1 | Ro | 35/36 | 97.2% | 85.8–99.5% | 25 |
| 2 | Hims & Hers | 34/36 | 94.4% | 81.9–98.5% | 5 |
| 3 | Mochi Health | 22/36 | 61.1% | 44.9–75.2% | 0 |
| 4 | LifeMD | 14/36 | 38.9% | 24.8–55.1% | 2 |
| 5 | Calibrate | 9/36 | 25.0% | 13.8–41.1% | 3 |
| 6 | Form Health | 8/36 | 22.2% | 11.7–38.1% | 0 |
| 7 | Henry Meds | 8/36 | 22.2% | 11.7–38.1% | 1 |
| 8 | Found | 5/36 | 13.9% | 6.1–28.7% | 0 |
| 9 | Eden | 3/36 | 8.3% | 2.9–21.8% | 0 |
Question group: Behavioral programs
60 returned four-engine answers to this group's 5 questions. No pooled group leader is asserted.
| # | Name | Named answers | Rate | 95% interval | Named first |
|---|---|---|---|---|---|
| 1 | Noom | 60/60 | 100.0% | 94.0–100.0% | 21 |
| 2 | WeightWatchers | 56/60 | 93.3% | 84.1–97.4% | 39 |
| 3 | Nutrisystem | 23/60 | 38.3% | 27.1–51.0% | 0 |
| 4 | Jenny Craig | 19/60 | 31.7% | 21.3–44.2% | 0 |
| 5 | Optavia | 12/60 | 20.0% | 11.8–31.8% | 0 |
Question group: Diet and calorie tracking apps
48 returned four-engine answers to this group's 4 questions. No pooled group leader is asserted.
| # | Name | Named answers | Rate | 95% interval | Named first |
|---|---|---|---|---|---|
| 1 | Cronometer | 47/48 | 97.9% | 89.1–99.6% | 21 |
| 2 | MyFitnessPal | 47/48 | 97.9% | 89.1–99.6% | 26 |
| 3 | Lose It! | 41/48 | 85.4% | 72.8–92.8% | 1 |
| 4 | MacroFactor | 22/48 | 45.8% | 32.6–59.7% | 0 |
| 5 | Carb Manager | 1/48 | 2.1% | 0.4–10.9% | 0 |
| 6 | Yazio | 0/48 | 0.0% | 0.0–7.4% | 0 |
Question group: Fasting and specialty diet apps
24 returned four-engine answers to this group's 2 questions. No pooled group leader is asserted.
| # | Name | Named answers | Rate | 95% interval | Named first |
|---|---|---|---|---|---|
| 1 | Fastic | 9/24 | 37.5% | 21.2–57.3% | 3 |
| 2 | Simple | 8/24 | 33.3% | 18.0–53.3% | 3 |
| 3 | Zero | 6/24 | 25.0% | 12.0–44.9% | 6 |
| 4 | Lumen | 0/24 | 0.0% | 0.0–13.8% | 0 |
Question group: Meal delivery for weight loss
24 returned four-engine answers to this group's 2 questions. No pooled group leader is asserted.
| # | Name | Named answers | Rate | 95% interval | Named first |
|---|---|---|---|---|---|
| 1 | Factor | 24/24 | 100.0% | 86.2–100.0% | 21 |
| 2 | Trifecta Nutrition | 23/24 | 95.8% | 79.8–99.3% | 3 |
| 3 | Green Chef | 9/24 | 37.5% | 21.2–57.3% | 0 |
| 4 | Territory Foods | 2/24 | 8.3% | 2.3–25.8% | 0 |
Question group: OTC products and supplements
24 returned four-engine answers to this group's 2 questions. No pooled group leader is asserted.
| # | Name | Named answers | Rate | 95% interval | Named first |
|---|---|---|---|---|---|
| 1 | Alli | 11/24 | 45.8% | 27.9–64.9% | 5 |
| 2 | Hydroxycut | 8/24 | 33.3% | 18.0–53.3% | 8 |
| 3 | Leanbean | 0/24 | 0.0% | 0.0–13.8% | 0 |
| 4 | PhenQ | 0/24 | 0.0% | 0.0–13.8% | 0 |
The top eight, side by side
| # | Name | Appearance rate | Answers and interval | Other measures |
|---|---|---|---|---|
| 1 | Wegovy | 39.2% | 113/288 answers · 95% CI 33.8–45% | first-mention position: 2; owned-domain citation (2/288): 0.7%; citation share: 0.1% |
| 2 | Zepbound | 33.7% | 97/288 answers · 95% CI 28.5–39.3% | first-mention position: 3; owned-domain citation (3/288): 1%; citation share: 0.1% |
| 3 | Noom | 33.3% | 96/288 answers · 95% CI 28.1–39% | first-mention position: 3; owned-domain citation (25/288): 8.7%; citation share: 1.5% |
| 4 | WeightWatchers | 31.9% | 92/288 answers · 95% CI 26.8–37.5% | first-mention position: 2.3; owned-domain citation (39/288): 13.5%; citation share: 1.7% |
| 5 | MyFitnessPal | 24.0% | 69/288 answers · 95% CI 19.4–29.2% | first-mention position: 2.2; owned-domain citation (13/288): 4.5%; citation share: 0.5% |
| 6 | Ozempic | 22.6% | 65/288 answers · 95% CI 18.1–27.7% | first-mention position: 3; owned-domain citation (0/288): 0%; citation share: 0% |
| 7 | Cronometer | 20.5% | 59/288 answers · 95% CI 16.2–25.5% | first-mention position: 2; owned-domain citation (11/288): 3.8%; citation share: 0.5% |
| 8 | Lose It! | 18.1% | 52/288 answers · 95% CI 14–22.9% | first-mention position: 3; owned-domain citation (2/288): 0.7%; citation share: 0.1% |
The four engines named the leading names at similar rates.
ChatGPT
72 asked · 72 returned · 72 grounded
Same questions, different answers
Claude
72 asked · 72 returned · 72 grounded
Gemini
72 asked · 72 returned · 72 grounded
Perplexity
72 asked · 72 returned · 72 grounded
Separate company view: medication makers
A maker counts once per answer if it or a tracked drug brand is named in 288 returned four-engine answers. Not the main brand ranking.
| # | Company | Named answers | Rate | 95% interval | Named first |
|---|---|---|---|---|---|
| 1 | Novo Nordisk | 113/288 | 39.2% | 33.8–45.0% | 86 |
| 2 | Eli Lilly | 98/288 | 34.0% | 28.8–39.7% | 27 |
Google AI Overviews were captured through 60 U.S. desktop searches and scored only where an overview appeared, so five-engine figures use 288 + 55 = 343 answers.
The fifth engine
Trigger rate: 55 of 60 searches
Google AI Overviews appeared on 55 of 60 searches (91.7%, CI 81.9–96.4%). The other 5 searches showed no overview. Within the 55 overviews, Wegovy was named in 20 (36.4%), WeightWatchers was named in 15 (27.3%), Zepbound was named in 14 (25.5%), Noom was named in 11 (20%). youtube.com was the most-cited source, with 60 citations and an appearance in 27 of 55 overviews.
| Five-engine rank | Name | Five-engine rate | Four-engine rank |
|---|---|---|---|
| 1 | Wegovy | 38.8% | 1 |
| 2 | Zepbound | 32.4% | 2 |
| 3 | Noom | 31.2% | 3 |
| 4 | WeightWatchers | 31.2% | 4 |
| 5 | MyFitnessPal | 22.2% | 5 |
| 6 | Ozempic | 21.6% | 6 |
| 7 | Cronometer | 20.4% | 7 |
| 8 | Lose It! | 16.9% | 8 |
| 9 | Saxenda | 14.3% | 9 |
| 10 | Mounjaro | 12.8% | 10 |
Who each question surfaces first
Six questions from the set. Each tile uses that question's own four-engine answers as the denominator.
| Question | Leader | Next | AI Overview |
|---|---|---|---|
| Q01 · 12 answers | Zepbound 100.0% | Wegovy 100.0%; Saxenda 100.0% | AI Overview shown on 3 of 3 searches |
| Q02 · 12 answers | Zepbound 100.0% | Wegovy 100.0% | AI Overview shown on 3 of 3 searches |
| Q03 · 12 answers | Ozempic 100.0% | Wegovy 100.0% | AI Overview shown on 3 of 3 searches |
| Q04 · 12 answers | Hims & Hers 100.0% | Ro 100.0%; Wegovy 100.0% | AI Overview shown on 3 of 3 searches |
| Q05 · 12 answers | Noom 100.0% | MyFitnessPal 83.3%; WeightWatchers 66.7% | AI Overview shown on 3 of 3 searches |
| Q06 · 12 answers | WeightWatchers 100.0% | Noom 100.0%; Wegovy 8.3% | AI Overview shown on 2 of 3 searches |
The four engines produced 2,465 citations in total. forbes.com was cited most often, with 122 citations (4.9%) across 75 answers. Next came healthline.com (89), fortune.com (79), garagegymreviews.com (51), weightwatchers.com (42), fda.gov (41).
Four AI engines · share of 288 grounded answers
Most-cited domains
Google AI Overviews · share of 55 overviews
Citation share by source type
Share of all citations by the type of site cited.
| Source type | Four AI engines (of 2,465 citations) | Google AI Overviews (of 339 citations) |
|---|---|---|
| Other / unclassified | 938 (38.1%) | 93 (27.4%) |
| General news / business press | 347 (14.1%) | 18 (5.3%) |
| Company / brand sites | 324 (13.1%) | 39 (11.5%) |
| Health publishers | 285 (11.6%) | 42 (12.4%) |
| Official / government | 245 (9.9%) | 9 (2.7%) |
| Review / comparison publishers | 134 (5.4%) | 9 (2.7%) |
| Community / social | 73 (3%) | 108 (31.9%) |
| Institutions / trade bodies | 32 (1.3%) | 11 (3.2%) |
| Reference | 32 (1.3%) | 6 (1.8%) |
| Research / data providers | 26 (1.1%) | 1 (0.3%) |
| Directories / rankings | 16 (0.6%) | 3 (0.9%) |
| Trade / specialist press | 13 (0.5%) | 0 (0%) |
How can weight loss brands improve their AI visibility?
These steps follow from the measured results above. They describe what the engines cited in this study and are not a guarantee of results.
| Step | What this study measured |
|---|---|
| Put your facts on your own domain. | WeightWatchers' own domains were cited in 13.5% of grounded answers, Noom's in 8.7% and MyFitnessPal's in 4.5%. |
| Keep your facts accurate on the sites engines cite. | The most-cited sites other than the tracked names' own were healthline.com (in 27.8% of grounded answers), forbes.com (26.0%), fortune.com (20.5%), garagegymreviews.com (17.7%) and drugs.com (11.1%). General news and business press supplied 14.1% of citations and health publishers 11.6%. |
| Check each engine separately. | Gemini named WeightWatchers in 37.5% of answers against 25.0% on ChatGPT. ChatGPT named Ozempic in 27.8% of answers against 15.3% on Claude. |
| Watch names outside the tracked list. | Qsymia (20 answers), Eli Lilly and Company (19 answers), Novo Nordisk A/S (19 answers), Contrave (17 answers), Xenical (14 answers) were named often but were not tracked. |
| Re-run the same questions every month. | Compare counts and intervals, not ranks. The 24 questions are in the appendix. |
What AI answers
Which weight loss and metabolic health brands appear in these AI answers?
Wegovy: 113/288 returned four-engine answers (39.2%; 95% interval 33.8–45.0%). Three or more leading intervals overlap; no sole leader is established.
Which tracked name is named first most often?
WeightWatchers was the first brand named in 51 of 288 answers, with an average first position of 2.3.
How often do Google AI Overviews appear for these questions?
An overview appeared on 55 of 60 searches (91.7%, CI 81.9–96.4%). Within those 55 overviews, Wegovy was named most often, in 20 (36.4%).
Which sources do the engines cite?
Across 2,465 four-engine citations, forbes.com was cited most (122 citations, in 75 of 288 grounded answers), followed by healthline.com (89 citations).
Do the four engines agree?
Largely. No tracked name differed by more than 12 points between engines.
How this study was measured
24 questions × 3 runs each × 4 AI engines = 288 answers + 60 Google searches · 55 AI Overviews
24 questions asked three times on each of ChatGPT, Claude, Gemini and Perplexity, measured November 5, 2026. United States, English; Google retrieval uses desktop results. Models: gpt-5-mini, claude-sonnet-5-5, gemini-3.6-flash only, sonar-pro. Google AI Overviews come from DataForSEO, not inferred chat answers. Appearance counts returned text, including ungrounded answers; citation rates use grounded answers. Longer overlapping names suppress shorter ones; First mention is the earliest eligible name order. Own-domain rates include declared domains and subdomains; shared parent scopes may count for multiple names and cannot be summed as unique citations.
| Engine | Model IDs called | Asked | Returned | Grounded |
|---|---|---|---|---|
| ChatGPT | gpt-5-mini | 72 | 72 | 72 |
| Claude | claude-sonnet-5-5 | 72 | 72 | 72 |
| Gemini | gemini-3.6-flash | 72 | 72 | 72 |
| Perplexity | sonar-pro | 72 | 72 | 72 |
| Google AI Overviews | DataForSEO Google SERP (live, advanced) | 60 | 55 shown | 55 |
Own-domain citations count a domain plus all its subdomains, with the same rule in every table.
Definitions
- Appearance rate: answers naming the tracked name ÷ answers returned, with Wilson 95% intervals.
- First mention: average order in which the tracked name first appears (1 = first).
- Own-domain citation: grounded answers citing the tracked name's domains ÷ grounded answers.
- Citation share: citations to the tracked name's domains ÷ all citations.
Limits
- Only 39 tracked brands are ranked; results are not an exhaustive market ranking.
- Only the tracked brands were scored. Untracked names that appeared often were not scored, including Qsymia (20 answers), Eli Lilly and Company (19 answers), Novo Nordisk A/S (19 answers), Contrave (17 answers), Xenical (14 answers).
- 348 of 360 planned results were returned. 12 AI Overview lookups were excluded after at most three total attempts.
- 60 successful Google searches: 55 overviews shown; 5 without an overview. Failures are excluded, not scored as zero.
- All returned chat answers had search sources.
- Questions 2, 3, 5 and 6 name Wegovy, Zepbound, Ozempic, Noom and WeightWatchers, so each of those counts includes up to 12 answers to a question that names it.
- Removing 4 Core questions naming tracked subjects leaves 240 eligible answers. The top two are Wegovy (88/240) and Zepbound (84/240); their order does not change.
- Names with no tracked own site are shown as None. Source types use Company / brand sites only for verified official organisations; other unresolved sites are Other / unclassified.
- Wilson 95% intervals are descriptive; overlapping leading intervals do not establish a sole leader. Measurements do not endorse medical, legal, financial or product claims.
- Informational questions only; the report states it is not medical advice and does not rank effectiveness. WeightWatchers has restructured and Jenny Craig has relaunched since the earlier edition. Generic names (semaglutide, tirzepatide, liraglutide, orlistat) are not counted as brand mentions. Telehealth weight-loss providers were added for this edition: Ro, Hims & Hers, Found, Calibrate, LifeMD, Henry Meds, Mochi Health, Eden and Form Health. The earlier edition excluded telehealth providers. Profile Plan and HMR announced in September 2024 that they had merged and operated under the HMR brand from July 2024. Profile’s website redirects to HMR. The current ultimate owner could not be confirmed from the reliable public sources checked; no present Sanford ownership is assumed.
- Google Shopping and unresolved google.com/goto links are excluded from cited sources; original URLs remain in the evidence.
- Named appearance is named_4 divided by n_4; own-site citation counts use grounded-answer denominators and are separate measures.
- Answers were collected through each engine's API using the model IDs listed in the methodology. The consumer ChatGPT, Claude, Gemini and Perplexity apps can answer differently.
Appendix: The 24 questions
Questions marked "Core question" are the original study questions, asked word for word. The others are added neutral questions.
| # | Question | Group | Source |
|---|---|---|---|
| 01 | What are the most effective weight loss medications? | Weight Loss Index 2.0 | Core question |
| 02 | Wegovy vs Zepbound which works better? | Weight Loss Index 2.0 | Core question |
| 03 | What is the difference between Ozempic and Wegovy? | Weight Loss Index 2.0 | Core question |
| 04 | Where can I get a GLP-1 prescription online? | Weight Loss Index 2.0 | Core question |
| 05 | Is Noom worth it? | Weight Loss Index 2.0 | Core question |
| 06 | WeightWatchers vs Noom which is better? | Weight Loss Index 2.0 | Core question |
| 07 | What is the best weight loss program? | Weight Loss Index 2.0 | Core question |
| 08 | What is the best calorie counting app? | Weight Loss Index 2.0 | Core question |
| 09 | What is the best free weight loss app? | Weight Loss Index 2.0 | Core question |
| 10 | What is the best intermittent fasting app? | Weight Loss Index 2.0 | Core question |
| 11 | What is the best meal delivery service for weight loss? | Weight Loss Index 2.0 | Core question |
| 12 | Do weight loss supplements work? | Weight Loss Index 2.0 | Core question |
| 13 | What happens when you stop taking a GLP-1? | Weight Loss Index 2.0 | Core question |
| 14 | Which prescription weight loss drugs are FDA approved? | Weight Loss Index 2.0 | Added question |
| 15 | Which online weight loss clinics offer GLP-1 medications? | Weight Loss Index 2.0 | Added question |
| 16 | How much do online weight loss programs with medication cost? | Weight Loss Index 2.0 | Added question |
| 17 | Which weight loss programs offer coaching? | Weight Loss Index 2.0 | Added question |
| 18 | What are the most popular diet programs in the US? | Weight Loss Index 2.0 | Added question |
| 19 | Which apps track macros most accurately? | Weight Loss Index 2.0 | Added question |
| 20 | Which apps help with a keto or low-carb diet? | Weight Loss Index 2.0 | Added question |
| 21 | Which meal delivery services offer high-protein meals? | Weight Loss Index 2.0 | Added question |
| 22 | Which over-the-counter weight loss products are FDA approved? | Weight Loss Index 2.0 | Added question |
| 23 | What are the side effects of GLP-1 medications? | Weight Loss Index 2.0 | Added question |
| 24 | Which weight loss apps work with smart scales or wearables? | Weight Loss Index 2.0 | Added question |
Related studies
- Mental Health and Therapy Index 2.0
- Menopause Index 2.0
- Med Spa Index 2.0
- Peptides and weight loss AI visibility study
About 5W
5W is an independent PR, creative and GEO agency founded in 2003, and we get you in the chatbox. All of our work is done in house, including media relations, site building and content. Learn more about our GEO practice or write to info@5wpr.com.
Full report
Read the PDF
Get in touch
Let's build your next chapter.
Tell us what you're working on. A senior strategist will respond within one business day.
- info@5wpr.com
- Phone
- 212.999.5585
- Offices
- Miami · HQ100 SE 2nd Street, Floor 38
Miami, FL 33131Tampa110 South 12th Street
Tampa, FL 33602New York469 7th Avenue, Floor 8
New York, NY 10018




